Conditions: Asthma, Exercise-Induced
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 51
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine the effect of an approved medication being studied in support of a new approach in the prevention of exercise-induced asthma (a worsening of asthma caused by exercise, also known as exercise-induced bronchospasm), in participants who have a history of worsening asthma after exercise.

Detailed description:

Arms:
arm 1: Montelukast - Placebo arm 2: Placebo - Montelukast

Interventions: intervention 1: Comparator: Montelukast intervention 2: Comparator: Placebo
Intervention descriptions: intervention 1: Montelukast 10 mg tablet administered orally as a single witnessed dose before exercise challenge intervention 2: Placebo tablet administered orally as a single witnessed dose before exercise challenge

Protocol document: